Literature DB >> 6444976

Immunologic investigations of mucoid strains of Pseudomonas aeruginosa: comparison of susceptibility to opsonic antibody in mucoid and nonmucoid strains.

R S Baltimore, M Mitchell.   

Abstract

Mucoid strains of Pseudomonas aeruginosa, isolated from patients with cystic fibrosis, were studied for the prevalence of each of the seven Fisher immunotype antigens and were compared with their nonmucoid transformants, obtained by repeated subculturing, for susceptibility to opsonic antibody. Of the 30 strains tested--one from each of 30 patients--16 were typable and were tested in the opsonophagocytic assay with use of immunotype-specific rabbit antiserum; eight had significant opsonization by complement without antiserum. Of the eight strains requiring antiserum, seven strains required a higher minimum concentration of antiserum for a 1.0 log10 reduction of viable P. aeruginosa than the paired nonmucoid derivative. These end-point titers were significantly greater for nonmucoid Pseudomonas (P = 0.0007). A mucoid strain not requiring antibody for opsonization was shown to use primarily the alternative complement pathway. These results are consistent with the hypothesis that the immunodeterminant for opsonic antibody in nonmucoid strains is blocked in the mucoid strain.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6444976     DOI: 10.1093/infdis/141.2.238

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  64 in total

Review 1.  Pathogenesis and management of lung disease in cystic fibrosis.

Authors:  M S Zach
Journal:  J R Soc Med       Date:  1991       Impact factor: 5.344

2.  Role of an alginate lyase for alginate transport in mucoid Pseudomonas aeruginosa.

Authors:  Sumita Jain; Dennis E Ohman
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

3.  Calcium-induced virulence factors associated with the extracellular matrix of mucoid Pseudomonas aeruginosa biofilms.

Authors:  S Sarkisova; M A Patrauchan; D Berglund; D E Nivens; M J Franklin
Journal:  J Bacteriol       Date:  2005-07       Impact factor: 3.490

Review 4.  Inflammation in the lung in cystic fibrosis. A vicious cycle that does more harm than good?

Authors:  M Berger
Journal:  Clin Rev Allergy       Date:  1991 Spring-Summer

5.  Nonopsonic phagocytosis of strains of Pseudomonas aeruginosa from cystic fibrosis patients.

Authors:  D P Speert; F Eftekhar; M L Puterman
Journal:  Infect Immun       Date:  1984-03       Impact factor: 3.441

6.  Cloning and expression in Pseudomonas aeruginosa of a gene involved in the production of alginate.

Authors:  J B Goldberg; D E Ohman
Journal:  J Bacteriol       Date:  1984-06       Impact factor: 3.490

7.  Nonopsonic antibodies in cystic fibrosis. Pseudomonas aeruginosa lipopolysaccharide-specific immunoglobulin G antibodies from infected patient sera inhibit neutrophil oxidative responses.

Authors:  I Eichler; L Joris; Y P Hsu; J Van Wye; R Bram; R Moss
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

8.  Staphylococcal exopolysaccharides inhibit lymphocyte proliferative responses by activation of monocyte prostaglandin production.

Authors:  R D Stout; K P Ferguson; Y N Li; D W Lambe
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

Review 9.  Mechanisms of phagocytosis and host clearance of Pseudomonas aeruginosa.

Authors:  Rustin R Lovewell; Yash R Patankar; Brent Berwin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-01-24       Impact factor: 5.464

10.  Isolation and characterization of an alginase from mucoid strains of Pseudomonas aeruginosa.

Authors:  A Linker; L R Evans
Journal:  J Bacteriol       Date:  1984-09       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.